Propiedad y actividad de insiders de Atea Pharmaceuticals, Inc. (AVIR): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $5.15 |
| Capitalización | $412M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-06-18 | Lucidi Bruno | M-Exempt | 29,600 | |
| 2026-06-18 | Lucidi Bruno | A-Award | 37,700 | $164K |
| 2026-06-18 | Lucidi Bruno | A-Award | 26,700 | |
| 2026-06-18 | Lucidi Bruno | M-Exempt | 29,600 | |
| 2026-06-18 | BERGER FRANKLIN M | M-Exempt | 29,600 | |
| 2026-06-18 | BERGER FRANKLIN M | A-Award | 37,700 | $164K |
| 2026-06-18 | BERGER FRANKLIN M | A-Award | 26,700 | |
| 2026-06-18 | BERGER FRANKLIN M | M-Exempt | 29,600 | |
| 2026-06-18 | Berman Howard | A-Award | 37,700 | $164K |
| 2026-06-18 | Berman Howard | A-Award | 26,700 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $34.5M | $21.7M | $850.1M | $764.4M | $646.7M | $143.8M | $64.7M | $95.7M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $434.3M | $390.0M | $206.1M |
| Cuentas por Cobrar | 0 | 0 | $5.8M | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $34.7M | $21.9M | $863.5M | $772.4M | $660.9M | $590.5M | $462.4M | $311.0M |
| Inmovilizado Material | $56000 | $41000 | $48000 | $184000 | $4.1M | $3.1M | $2.1M | $1.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $34.9M | $22.1M | $863.6M | $772.9M | $666.7M | $595.0M | $464.7M | $315.2M |
| Cuentas por Pagar | $391000 | $548000 | $60000 | $4.5M | $2.6M | $4.3M | $4.5M | $12.9M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $843000 |
| Pasivos Corrientes | $1.8M | $2.4M | $315.8M | $56.9M | $18.5M | $32.4M | $18.6M | $39.8M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $71.0M | $2.5M | $315.8M | $62.8M | $26.1M | $39.8M | $25.8M | $39.8M |
| Reservas | -$40.2M | -$54.2M | -$65.2M | $56.0M | -$59.9M | -$195.8M | -$364.2M | -$522.6M |
| Patrimonio Neto | -$36.2M | $19.5M | $547.8M | $710.1M | $640.6M | $555.2M | $438.9M | $275.4M |
| Deuda Total | 0 | 0 | 0 | $197000 | $3.1M | $2.4M | $1.6M | $843000 |
| Deuda Neta | -$34.5M | -$21.7M | -$850.1M | -$764.2M | -$643.6M | -$575.7M | -$453.1M | -$301.0M |
| Capital Circulante | $32.9M | $19.5M | $547.7M | $715.5M | $642.4M | $558.1M | $443.8M | $271.2M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 8.13 |
Rentabilidad
| Rentabilidad sobre capital | -64.25% |
| Rentabilidad sobre capital invertido | -86.35% |
| Rentabilidad sobre activos | -71.16% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ACHV · ALLO · ARCT · ENTA · HUMA · PYXS · TRDA
Explorar sector: Healthcare · Biotechnology
Más secciones de AVIR: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones